Do the patients with peripheral atherosclerosis need to a medical therapy before the revascularization?

In the review article are provided the approaches to the therapy for improvement of prognosis in patients with peripheral and multifocal atherosclerosis which are available now; some limitations and a real situation are designated for the antithrombotic therapy in this category of patients. Accordin...

Full description

Bibliographic Details
Main Authors: O L Barbarash, V V Kashtalap
Format: Article
Language:Russian
Published: "Consilium Medicum" Publishing house 2019-12-01
Series:Терапевтический архив
Subjects:
Online Access:https://ter-arkhiv.ru/0040-3660/article/viewFile/33757/pdf
_version_ 1818500898394996736
author O L Barbarash
V V Kashtalap
author_facet O L Barbarash
V V Kashtalap
author_sort O L Barbarash
collection DOAJ
description In the review article are provided the approaches to the therapy for improvement of prognosis in patients with peripheral and multifocal atherosclerosis which are available now; some limitations and a real situation are designated for the antithrombotic therapy in this category of patients. According to the clinical trial COMPASS the prospects of wide use of a combination of acetylsalicylic acid and a rivaroxsaban of 2.5 mg 2 times a day in the patients with chronic coronary heart disease and/or symptom peripheral atherosclerosis are designated.
first_indexed 2024-12-10T20:48:53Z
format Article
id doaj.art-19afaf35dc8041899983b595fa05f907
institution Directory Open Access Journal
issn 0040-3660
2309-5342
language Russian
last_indexed 2024-12-10T20:48:53Z
publishDate 2019-12-01
publisher "Consilium Medicum" Publishing house
record_format Article
series Терапевтический архив
spelling doaj.art-19afaf35dc8041899983b595fa05f9072022-12-22T01:34:10Zrus"Consilium Medicum" Publishing houseТерапевтический архив0040-36602309-53422019-12-01911212913410.26442/00403660.2019.12.00049830485Do the patients with peripheral atherosclerosis need to a medical therapy before the revascularization?O L Barbarash0V V Kashtalap1Research Institute for Complex Issues of Cardiovascular Diseases; Kemerovo State Medical UniversityResearch Institute for Complex Issues of Cardiovascular Diseases; Kemerovo State Medical UniversityIn the review article are provided the approaches to the therapy for improvement of prognosis in patients with peripheral and multifocal atherosclerosis which are available now; some limitations and a real situation are designated for the antithrombotic therapy in this category of patients. According to the clinical trial COMPASS the prospects of wide use of a combination of acetylsalicylic acid and a rivaroxsaban of 2.5 mg 2 times a day in the patients with chronic coronary heart disease and/or symptom peripheral atherosclerosis are designated.https://ter-arkhiv.ru/0040-3660/article/viewFile/33757/pdfperipheral atherosclerosischronic coronary heart diseasemultifocal atherosclerosisprognosisantithrombotic therapyrivaroxaban
spellingShingle O L Barbarash
V V Kashtalap
Do the patients with peripheral atherosclerosis need to a medical therapy before the revascularization?
Терапевтический архив
peripheral atherosclerosis
chronic coronary heart disease
multifocal atherosclerosis
prognosis
antithrombotic therapy
rivaroxaban
title Do the patients with peripheral atherosclerosis need to a medical therapy before the revascularization?
title_full Do the patients with peripheral atherosclerosis need to a medical therapy before the revascularization?
title_fullStr Do the patients with peripheral atherosclerosis need to a medical therapy before the revascularization?
title_full_unstemmed Do the patients with peripheral atherosclerosis need to a medical therapy before the revascularization?
title_short Do the patients with peripheral atherosclerosis need to a medical therapy before the revascularization?
title_sort do the patients with peripheral atherosclerosis need to a medical therapy before the revascularization
topic peripheral atherosclerosis
chronic coronary heart disease
multifocal atherosclerosis
prognosis
antithrombotic therapy
rivaroxaban
url https://ter-arkhiv.ru/0040-3660/article/viewFile/33757/pdf
work_keys_str_mv AT olbarbarash dothepatientswithperipheralatherosclerosisneedtoamedicaltherapybeforetherevascularization
AT vvkashtalap dothepatientswithperipheralatherosclerosisneedtoamedicaltherapybeforetherevascularization